Autoantibodies in lupus nephritis useful in distinguishing proliferative nephritis from membranous nephritis
Modern Rheumatology · 2023
DOI: 10.1093/mr/roac143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, 2023. Verfasst von Yuko Asanuma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Lupus Nephritis, Lupus Erythematosus, Systemic, Glomerulonephritis, Membranous. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Objectives
This study was conducted to determine autoantibodies associated with lupus nephritis (LN), especially those useful in diagnosing proliferative and membranous nephritis.
Methods
A total of 106 patients with LN and 63 patients with systemic lupus erythematosus but no nephritis were enrolled; then, 55 patients were selected from the LN group and were divided into two groups: proliferative nephritis patients (n = 36) and membranous nephritis patients (n = 19). The autoantibody profiles of patients’ sera were evaluated using the EUROLINE ANA Profile 3 (IgG) kit.
Results
A higher positivity rate of anti-double-stranded DNA antibody and anti-histone antibody was seen in LN patients compared to nonrenal systemic lupus erythematosus patients. In comparing between proliferative and membranous nephritis, the positivity of anti-nucleosome antibody was higher in proliferative nephritis, although it was not statistically significant. However, anti-nucleosome antibody–positive patients with LN had a higher prevalence of haematuria and pyuria, which are strong indications of proliferative nephritis. Also, a significantly higher positivity rate of anti-RNP70 antibody was seen in membranous nephritis compared to proliferative nephritis.
Conclusions
Our results showed that anti-nucleosome and anti-RNP70 antibodies may be predictive nonhistological factors for discriminating between proliferative and membranous LN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.
- Department of Internal Medicine and Rheumatology, Juntendo University Koshigaya Hospital, Saitama, Japan.
ORCID-Profile: Yuko Asanuma
Zitieren
APA
Asanuma, Y., Nozawa, K., Matsushita, M., Kusaoi, M., Abe, Y., Yamaji, K., & Tamura, N. (2023). Autoantibodies in lupus nephritis useful in distinguishing proliferative nephritis from membranous nephritis. Modern Rheumatology. https://doi.org/10.1093/mr/roac143
Vancouver
Asanuma Y, Nozawa K, Matsushita M, Kusaoi M, Abe Y, Yamaji K, et al. Autoantibodies in lupus nephritis useful in distinguishing proliferative nephritis from membranous nephritis. Modern Rheumatology. 2023. doi:10.1093/mr/roac143
BibTeX
@article{Asanuma2023,
author = {Asanuma, Yuko and Nozawa, Kazuhisa and Matsushita, Masakazu and Kusaoi, Makio and Abe, Yoshiyuki and Yamaji, Ken and Tamura, Naoto},
title = {Autoantibodies in lupus nephritis useful in distinguishing proliferative nephritis from membranous nephritis},
journal = {Modern Rheumatology},
year = {2023},
doi = {10.1093/mr/roac143}
}
EUVIMED